Fed. Circ. Keeps Tyco Appeal Alive In Restoril Row

Law360, New York (January 27, 2011, 8:04 PM EST) -- The Federal Circuit on Thursday denied the former Mutual Pharmaceutical Co. Inc.'s bid to scrap Tyco Healthcare Group LP’s appeal in a suit alleging Mutual infringed four Tyco patents in creating a generic version of the sleep aid Restoril.

The U.S. Court of Appeals for the Federal Circuit rejected Mutual’s motion to dismiss, saying the company failed to show that a lower court improperly entered final judgment against Tyco, allowing it to appeal.

Mutual, now known as URL Pharma Inc., argued that the U.S. District Court...
To view the full article, register now.